Mitochondrial noncoding RNA-regulatory network in cardiovascular disease

Basic Research in Cardiology
Amela JusicEU-CardioRNA COST Action (CA17129)

Abstract

Mitochondrial function and integrity are vital for the maintenance of cellular homeostasis, particularly in high-energy demanding cells. Cardiomyocytes have a large number of mitochondria, which provide a continuous and bulk supply of the ATP necessary for cardiac mechanical function. More than 90% of the ATP consumed by the heart is derived from the mitochondrial oxidative metabolism. Decreased energy supply as the main consequence of mitochondrial dysfunction is closely linked to cardiovascular disease (CVD). The discovery of noncoding RNA (ncRNAs) in the mitochondrial compartment has changed the traditional view of molecular pathways involved in the regulatory network of CVD. Mitochondrial ncRNAs participate in controlling cardiovascular pathogenesis by regulating glycolysis, mitochondrial energy status, and the expression of genes involved in mitochondrial metabolism. Understanding the underlying mechanisms of the association between impaired mitochondrial function resulting from fluctuation in expression levels of ncRNAs and specific disease phenotype can aid in preventing and treating CVD. This review presents an overview of the role of mitochondrial ncRNAs in the complex regulatory network of the cardiovascular pathology...Continue Reading

References

Jan 6, 2007·Science·Hun-Way HwangJoshua T Mendell
Feb 27, 2009·Basic Research in Cardiology·Charles SteenbergenElizabeth Murphy
Apr 7, 2009·The FEBS Journal·Qun LinZhong Yun
May 13, 2009·Nature Reviews. Cardiology·Michael V G Latronico, Gianluigi Condorelli
Jul 25, 2009·RNA·Joan C Ritland PolitzThoru Pederson
Dec 17, 2009·The Journal of Biological Chemistry·Hitoo NishiTakeshi Kimura
Jan 21, 2010·American Journal of Physiology. Endocrinology and Metabolism·Wataru AoiToshikazu Yoshikawa
Nov 3, 2010·International Journal of Oncology·Chunzhi ZhangChunsheng Kang
May 18, 2011·Proceedings of the National Academy of Sciences of the United States of America·Alberto DávalosCarlos Fernández-Hernando
Jun 4, 2011·PloS One·Eric BarreyXavier Gidrol
Jun 23, 2011·PloS One·Simonetta BandieraAlexandra Henrion-Caude
Jul 2, 2011·Journal of the American Society of Nephrology : JASN·Xue-Yuan BaiXiang-Mei Chen
Sep 1, 2011·The Journal of Biological Chemistry·Sanjay YadavDevendra Parmar
Dec 17, 2011·International Journal of Molecular Sciences·Tao WangXuewei Li
Apr 21, 2012·Circulation Research·Samarjit DasCharles Steenbergen
Apr 28, 2012·The Journal of Biological Chemistry·Claudio VillotaLuis O Burzio
Jun 23, 2012·Nature·Dimitrios G ZisoulisAmy E Pasquinelli
Jan 11, 2013·Biological & Pharmaceutical Bulletin·Kosuke EndoNaoharu Iwai
Mar 13, 2013·Cell Research·Seungil RoWei Yan
Apr 30, 2013·Cell·Taiowa A Montgomery, Gary Ruvkun
Sep 11, 2013·Biochimica Et Biophysica Acta·Marco TomasettiLanfeng Dong
Sep 18, 2013·American Journal of Physiology. Heart and Circulatory Physiology·Sergey I Dikalov, Zoltan Ungvari
Jan 7, 2014·Pflügers Archiv : European journal of physiology·Theodor BaarsPetra Kleinbongard
Jan 8, 2014·Biochemical and Biophysical Research Communications·San-Zhong LiZhou Fei
Feb 22, 2014·Circulation Research·Kun WangPei-Feng Li
Mar 13, 2014·Molecular and Cellular Biology·Jincheng LiPeifeng Li
Mar 26, 2014·Circulation Research·Regalla KumarswamyThomas Thum
Apr 1, 2014·Cell·Thomas R Cech, Joan A Steitz
May 3, 2014·PloS One·Wino J WijnenEsther E Creemers
Jul 19, 2014·Circulation Research·Mélanie VausortYvan Devaux
Sep 10, 2014·Nature Reviews. Cardiology·Thomas Thum
Sep 23, 2014·Journal of the American Heart Association·Neus BelleraDavid Garcia-Dorado
Sep 30, 2014·Genes·Filipe V DuarteAnabela P Rolo

❮ Previous
Next ❯

Citations

Jul 16, 2020·International Journal of Molecular Sciences·Amela Jusic On Behalf Of The Eu-CardioRNA Cost Action
Sep 9, 2020·Journal of Cellular and Molecular Medicine·Lei LiuYifei Li
Dec 30, 2020·Biology·Sílvia C RodriguesFilipe V Duarte
Feb 9, 2021·Frontiers in Cell and Developmental Biology·Qian LiWeijun Fu
Jan 23, 2021·Diagnostics·Nurruzanna IsmailSiti Aishah Sulaiman
Jul 19, 2020·Archives of Cardiovascular Diseases·Luc RochetteCatherine Vergely
Jun 11, 2021·RNA Biology·Huixin LiangQiyi Zhao
Jun 15, 2021·Frontiers in Pharmacology·Guang-Qiong ZhangXiang-Chun Shen
Aug 3, 2021·Cardiology Research and Practice·Ziyang HuShibin Zhang
Jul 8, 2021·Journal of Cardiovascular Pharmacology·Yibo LiGuoan Zhao
Aug 17, 2021·Frontiers in Cell and Developmental Biology·Xu Liu, Ge Shan
Aug 31, 2021·Clinical and Translational Medicine·Liyang LiXiangdong Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiovascular Homeostasis

Cardiovascular regulation and homeostasis is important in maintaining health and dysfunction may lead to cardiovascular diseases. Nitric oxide and vascular endothelium are one of many molecules involved in the homeostatic mechanism. Here is the latest research on cardiovascular homeostasis.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.